Sponsor:
University of Toronto
Code:
NCT01196325
Conditions
Diabetic Macular Edema
Eligibility Criteria
Sex: All
Age: 35 - 70+
Healthy Volunteers: Accepted
Brief summary:
Conditions
Diabetic Macular Edema
Study ID
NCT01196325
Start date
Jul, 2009
Status verified date
Jan, 2013
Completion date
Aug, 2014
Anticipated
Primary completion date
Aug, 2014
Anticipated
Eligibility Criteria
Sex: All
Age: 35 - 70+
Healthy Volunteers: Accepted
Enrollment
64 participants
Anticipated
Arms
Laser Group
Anti-VEGF Group (Bevacizumab)
Anti-VEGF Group (Ranibizumab)
Age-matched controls
Primary outcome measure
Central contacts
Locations
Toronto Western Hospital
Recruiting
Toronto, Ontario, Canada, M5T2S8
Contacts
Principal Investigator:
Christopher Hudson, PhD
Sponsor
University of Toronto
Last update posted
Jan 24, 2013
Last verified
Jan, 2013
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Toronto on 2013-01-24.